New prostaglandin derivative for glaucoma treatment
A hydrogen sulphide-releasing derivative of latanoprost acid (ACS 67) was synthesized and tested in vivo to evaluate its activity on reduction of intraocular pressure and tolerability. Glutathione (GSH) and cGMP content were also measured in the aqueous h
Perrino, Elena,Uliva, Caterina,Lanzi, Cecilia,Soldato, Piero Del,Masini, Emanuela,Sparatore, Anna
The present invention relates to new prostaglandin derivatives having improved pharmacological activity and enhanced tolerability. They can be employed for the treatment of glaucoma and ocular hypertension.
-
Page/Page column 4
(2010/07/08)
PROSTAGLANDIN PHARMACEUTICAL COMPOSITIONS
The present invention relates to new prostaglandin derivatives having improved pharmacological activity and enhanced tolerability. They can be employed for the treatment of glaucoma and ocular hypertension.
-
Page/Page column 19-20
(2009/01/20)
More Articles about upstream products of 1088434-86-9